Has Fernando Galan received payments from drug or device companies?

Yes. Drug and device makers reported $13,241 in general payments to Fernando Galan across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Fernando Galan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Fernando Galan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Fernando Galan

Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1427496850

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Biocodex, Inc. at 49.6% of the total. 2025 is the largest year on record at $11,437, more than ten times the $517 reported in 2019.

$13,241in general payments, 2019–2025

Across 78 payments — averaging $169.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biocodex, Inc.$7K
UCB, Inc.$3K
Jazz Pharmaceuticals Inc.$2K
Neuropace, Inc.$461
Neurelis, Inc.$154
Livanova USA, Inc.$122
plus $317 from 8 others

$89,591in research payments, 2019–2025

Across 12 payments — averaging $7465.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Immedica Pharma US, Inc.$90K
UCB SA$51

What the payments were for

Consulting fees$6,62050%
Travel & lodging$3,25525%
Food & beverage$3,36725%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biocodex, Inc.	8	$6,562
UCB, Inc.	20	$3,296
Jazz Pharmaceuticals Inc.	22	$2,329
Neuropace, Inc.	8	$461
Neurelis, Inc.	6	$154
Livanova USA, Inc.	1	$122
Greenwich Biosciences, Inc.	4	$93
Monteris Medical Corporation	1	$59
Eisai Inc.	2	$40
Aquestive Therapeutics, Inc.	2	$36
Upsher-smith Laboratories LLC	1	$29
Otter Pharmaceuticals, LLC	1	$26
Zogenix Inc.	1	$21
Novartis	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,241 in reported general payments places this provider in the 75th percentile of 137 neurology with special qualifications in child neurology providers in Florida.

See all neurology with special qualifications in child neurology providers in Florida →

Other neurology with special qualifications in child neurology in Miami

Trevor ResnickMiami$230K
Migvis MonduyMiami$188K
Elza VasconcellosMiami$170K
Ian MillerMiami$104K
Matt LallasMiami$88K
Marytery FajardoMiami$44K
Paula SchleiferMiami$31K
Roberto Lopez-AlberolaMiami$31K
Anuj JayakarMiami$24K
Walter BradleyMiami$19K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →